Clinical and pathological features of breast disease in Cowden's syndrome: an underrecognized syndrome with an increased risk of breast cancer

scientific article

Clinical and pathological features of breast disease in Cowden's syndrome: an underrecognized syndrome with an increased risk of breast cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0046-8177(98)90389-6
P698PubMed publication ID9445133

P2093author name stringD Schneider
M Peacocke
H C Tsou
A C Gruener
C A Schrager
P2860cites workCowden's disease. A possible new symptom complex with multiple system involvementQ28189705
Multiple sclerotic fibromas of the skin. A cutaneous marker of Cowden's diseaseQ35514372
Mammary hamartoma--a review of 35 casesQ35982597
Cowden syndrome and Lhermitte-Duclos diseaseQ36377297
Lobular carcinoma in a mammary hamartomaQ37108361
Cowden's disease (multiple hamartoma and neoplasia syndrome). A case report and review of the English literatureQ40272335
Proliferative breast "disease". An unresolved diagnostic dilemmaQ40915239
The dermatopathology of Cowden's syndrome*Q41724692
Clinical and Pathological Features of Ovarian Cancer in Women with Germ-Line Mutations ofBRCA1Q63183299
Fibromatosis of the breastQ66991177
Cowden's disease: a cutaneous marker of breast cancerQ67339601
The cutaneous pathology of Cowden's disease: new findingsQ69383662
The Cowden syndrome: a clinical and genetic study in 21 patientsQ69486172
The cutaneous pathology of facial lesions in Cowden's diseaseQ70714853
The cutaneous pathology of extrafacial lesions in Cowden's diseaseQ70714855
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectbreast cancerQ128581
P304page(s)47-53
P577publication date1998-01-01
P1433published inHuman PathologyQ15756731
P1476titleClinical and pathological features of breast disease in Cowden's syndrome: an underrecognized syndrome with an increased risk of breast cancer
P478volume29

Reverse relations

cites work (P2860)
Q53395186A hypothesis about tumour development and the clinical features of hereditary breast cancers.
Q46556329Acute-onset cerebellar symptoms in Lhermitte-Duclos disease: case report
Q33740171Allele-specific tumor spectrum in pten knockin mice
Q91872241Benign Breast Tumours - Diagnosis and Management
Q37785234Breast Cancer Predisposition Syndromes
Q73823045Breast hamartoma: fine-needle aspiration cytologic finding
Q44066352Breast hamartomas: clinicopathological and immunohistochemical studies of 24 cases
Q35953604Challenges in the management of a patient with Cowden syndrome: case report and literature review
Q37690575Common breast cancer risk variants in the post-COGS era: a comprehensive review
Q94601518Cowden Syndrome Diagnosed by Bilateral Breast Cancer with Lhermitte-Duclos Disease: A Case Report
Q30978301Cowden disease with Lhermitte-Duclos disease: case report.
Q84877384Cowden syndrome
Q37313091Cowden syndrome: a critical review of the clinical literature
Q47890517Cowden syndrome: mucocutaneous lesions as precursors of internal malignancy.
Q38240785Cowden syndrome: recognizing and managing a not-so-rare hereditary cancer syndrome
Q81318238Evaluation of breast involvement in relation to Cowden syndrome: a radiological and clinicopathological study of patients with PTEN germ-line mutations
Q33533301Exploring the gain of function contribution of AKT to mammary tumorigenesis in mouse models
Q33915583Genes implicated in hereditary breast cancer syndromes
Q36843211Genetic counseling and testing for common hereditary breast cancer syndromes: a paper from the 2007 William Beaumont hospital symposium on molecular pathology
Q37305035Genetic modelling of the PTEN/AKT pathway in cancer research
Q35447362Genetics of skin appendage neoplasms and related syndromes
Q44173483Germline mutations in the PTEN gene in Israeli patients with Bannayan-Riley-Ruvalcaba syndrome and women with familial breast cancer
Q83767560Hamartomatous polyposis syndromes
Q28085485Hereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment?
Q54996503Inherited predisposition to endometrial cancer: Moving beyond Lynch syndrome
Q37602377Inhibiting PI3K as a therapeutic strategy against cancer
Q28359884Male breast cancer in Cowden syndrome patients with germline PTEN mutations
Q34173563Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations
Q51155217Mosaic partial deletion of the PTEN gene in a patient with Cowden syndrome.
Q38221583Multiple primary cancers as a guide to heritability
Q30416540Myoid hamartoma of the breast with focal chondromyoxid metaplasia and pseudoangiomatous stromal hyperplasia: A case report
Q37546115Novel inhibitors of the PI3K family
Q92879774PTEN Hamartoma Tumor Syndrome: A Clinical Overview
Q24801835PTEN deficiency: a role in mammary carcinogenesis
Q34824223PTEN hamartoma tumor syndromes.
Q36753139PTEN, more than the AKT pathway
Q28203387PTEN: one gene, many syndromes
Q57590810PTENHamartoma Tumor Syndrome
Q37852615Phenotype-genotype correlation in familial breast cancer
Q35432463Phenotypic findings of Cowden syndrome and Bannayan-Zonana syndrome in a family associated with a single germline mutation in PTEN
Q51324972Sclerotic fibroma (storiform collagenoma)-like stroma in a fibroadenoma of axillary accessory breast tissue.
Q36017160Storiform collagenoma as a clue for Cowden disease or PTEN hamartoma tumour syndrome
Q24678674The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation
Q34229795The PTEN/PI3K/AKT Pathway in vivo, Cancer Mouse Models
Q51298108The clinical consequences of hemizygosity across 2 MB of 10q23 are restricted to Cowden syndrome.
Q34639877The contribution of inherited factors to the clinicopathological features and behavior of breast cancer
Q37521382The gene dosage of class Ia PI3K dictates the development of PTEN hamartoma tumor syndrome
Q36018533The hamartomatous polyposis syndromes: a clinical and molecular review
Q34263162Translational advances regarding hereditary breast cancer syndromes
Q37412593Validation of transgenic models of breast cancer: ductal carcinoma in situ (DCIS) and Brca1-mutation-related breast cancer

Search more.